|
NCAPD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.2711000004565E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.87009999999388E-05 |
| Normal-vs-Stage2 |
4.463200E-03 |
| Normal-vs-Stage3 |
5.18490000045446E-07 |
| Normal-vs-Stage4 |
2.31679999999068E-05 |
| Stage1-vs-Stage2 |
9.145200E-01 |
| Stage1-vs-Stage3 |
6.111800E-02 |
| Stage1-vs-Stage4 |
1.582030E-01 |
| Stage2-vs-Stage3 |
1.675420E-01 |
| Stage2-vs-Stage4 |
2.245400E-01 |
| Stage3-vs-Stage4 |
9.916200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.72899999995035E-06 |
| Normal-vs-AfricanAmerican |
6.312300E-02 |
| Normal-vs-Asian |
2.820800E-03 |
| Caucasian-vs-AfricanAmerican |
3.009600E-01 |
| Caucasian-vs-Asian |
5.909400E-01 |
| AfricanAmerican-vs-Asian |
5.727000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.50149999997596E-06 |
| Normal-vs-Female |
3.11389999996248E-06 |
| Male-vs-Female |
6.236400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.406600E-04 |
| Normal-vs-Age(41-60Yrs) |
4.59429999999372E-06 |
| Normal-vs-Age(61-80Yrs) |
9.39149999990008E-07 |
| Normal-vs-Age(81-100Yrs) |
3.162000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.172600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.818400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.159800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.270600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.024800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.797400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.897800E-03 |
| Classical-VS-Follicular |
8.634900E-04 |
| Classical-VS-Other |
8.568800E-01 |
| Classical-VS-Normal |
1.641330E-04 |
| Tall-VS-Follicular |
7.103800E-01 |
| Tall-VS-Other |
4.993800E-01 |
| Tall-VS-Normal |
2.20539999999936E-05 |
| Follicular-VS-Other |
4.646400E-01 |
| Follicular-VS-Normal |
6.7019000005164E-07 |
| Other-VS-Normal |
1.477230E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.01749999999556E-05 |
| Normal-vs-N1 |
7.40389999975832E-07 |
| N0-vs-N1 |
8.572200E-02 |
|
|
